Takashi Kei Kishimoto

Chief Scientific Officer at Selecta Biosciences

Takashi Kei Kishimoto is the current Chief Scientific Officer at Selecta Biosciences. Prior to joining Selecta, they were Vice President of Biology at Momenta Pharmaceuticals from March 2006 to July 2011. From October 1999 to March 2006, they were Sr Director of Inflammation at Millennium Pharmaceuticals. Takashi began their career in the pharmaceutical industry as Associate Director of Inflammation at Boehringer Ingelheim, where they worked from June 1990 to October 1999.

Takashi Kei Kishimoto is currently a PhD candidate at Harvard University in the field of immunology. Takashi was formerly a post-doctoral fellow at Stanford University in the same field. Takashi holds a B.A. from New College of Florida in biology.

They work with Elona Kogan - General Counsel and Corporate, Kevin Tan - Chief Financial Officer, and Lloyd Johnston - COO. Their manager is Carsten Brunn, President and CEO.

Timeline

  • Chief Scientific Officer

    Current role

View in org chart